fluorodeoxyuridylate has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, P; Carosati, E; Costi, MP; Cruciani, G; Farina, D; Ferrari, S; Finer-Moore, J; Guaitoli, G; Luciani, R; Marverti, G; Stroud, RM; Tochowicz, A | 1 |
| Kashani-Sabet, M; Lu, Y; Ma, J; Newman, E; Scanlon, KJ | 1 |
| Lu, Y; Newman, EM; Priest, DG; Scanlon, KJ | 1 |
3 other study(ies) available for fluorodeoxyuridylate and Cancer of Ovary
| Article | Year |
|---|---|
Inhibitor of ovarian cancer cells growth by virtual screening: a new thiazole derivative targeting human thymidylate synthase.
Topics: Acetanilides; Antineoplastic Agents; Cisplatin; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Female; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Ovarian Neoplasms; Structure-Activity Relationship; Thiazoles; Thymidylate Synthase; Tumor Cells, Cultured | 2012 |
Mechanisms for cisplatin-FUra synergism and cisplatin resistance in human ovarian carcinoma cells both in vitro and in vivo.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Cell Division; Cell Line; Cell Survival; Cisplatin; Drug Synergism; Female; Fluorodeoxyuridylate; Fluorouracil; Humans; Ovarian Neoplasms; RNA, Neoplasm; Thymidylate Synthase; Tumor Cells, Cultured | 1988 |
Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.
Topics: Carcinoma; Cell Line; Cisplatin; Drug Synergism; Female; Fluorodeoxyuridylate; Fluorouracil; Folic Acid; Humans; Ovarian Neoplasms; Tetrahydrofolates; Thymidine Monophosphate; Thymidylate Synthase | 1986 |